Number of pages: 68
Posted: 14 Jul 2022
Andrea Charlotte Pichler,
Nadège Carrié,
Allison Voisin,
Samira Ghazali,
Liliana Lucca,
Marie Tosolini,
Marine Cuisinier,
Laura Do Souto,
Rüçhan Ekren,
Eve Blanquart, Lea Lemaitre,
Virginie Feliu,
Marie-Véronique Joubert,
Céline Mazzotti,
Camille Guillerey,
Tania Watts,
Benoit Salomon,
Olivier Joffre,
Yenkel Grinberg-Bleyer,
Hervé Avet-Loiseau and
Ludovic Martinet
Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), Centre de Recherche en Cancérologie de Lyon, Université Toulouse III - Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, University of Toronto - Department of Immunology, Université Toulouse III - Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Toulouse III - Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Centre de Recherche en Cancérologie de Lyon, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT) and University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT)
